Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
822.5500 16.00 (1.98%)
NSE Oct 03, 2025 15:31 PM
Volume: 331.0K
 

logo
Natco Pharma Ltd.
08 Aug 2017
822.55
1.98%
buy
Results Update: Natco Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter. Revenue decreased by 25.91% to Rs. 428.1 Cr in Q1FY18 when compared to the previous quarter.
 
Natco Pharma Ltd. has an average target of 1294.50 from 4 brokers.
More from Natco Pharma Ltd.
Recommended
Five Interesting Stocks Today - October 3, 2025
The Baseline | 03 Oct 2025, 04:45PM
Market closes higher, PTC Industries’ arm wins contract to supply RDH parts to Coolbrook
Trendlyne Marketwatch | 03 Oct 2025, 04:04PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020